Effects of inhibition of interleukin-6 signalling on insulin sensitivity and lipoprotein (a) levels in human subjects with rheumatoid diseases.
Interleukin-6 (IL-6) is a pro-inflammatory cytokine that has been found to be increased in type 2 diabetic subjects. However, it still remains unclear if these elevated IL-6 levels are co-incidental or if this cytokine is causally related to the development of insulin resistance and type 2 diabetes...
Main Authors: | Olaf Schultz, Frank Oberhauser, Jasemine Saech, Andrea Rubbert-Roth, Moritz Hahn, Wilhelm Krone, Matthias Laudes |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2010-12-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3001451?pdf=render |
Similar Items
-
Association between the interleukin-6 promoter polymorphism -174G/C and serum lipoprotein(a) concentrations in humans.
by: Heiner K Berthold, et al.
Published: (2011-01-01) -
Pro-inflammatory wnt5a and anti-inflammatory sFRP5 are differentially regulated by nutritional factors in obese human subjects.
by: Dominik M Schulte, et al.
Published: (2012-01-01) -
Hypoadiponectinemia in extremely low gestational age newborns with severe hyperglycemia--a matched-paired analysis.
by: Andre Oberthuer, et al.
Published: (2012-01-01) -
Insulin Resistance Predicts Atherogenic Lipoprotein Profile in Nondiabetic Subjects
by: Flávia De C. Cartolano, et al.
Published: (2017-01-01) -
The roles of interleukin-16 and insulin-like growth factor-1 receptor in rheumatoid arthritis
by: Chih-NengTsai, et al.
Published: (2011)